Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Haematology

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bjh.12545PMID 23992039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring

  2012cited by this paper
• First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

  2012cited by this paper
• Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

  2012cited by this paper
• Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

  2011influential reference
• Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation.

  2010cited by this paper
• Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

  2010influential reference
• Pathogenesis and management of graft-versus-host disease.

  2010cited by this paper
• MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

  2009cited by this paper
• Comprar Thomas' Hematopoietic Cell Transplantation, 4th Edition | Karl G. Blume | 9781405153485 | Wiley

  2009cited by this paper
• Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses.

  2008cited by this paper
• Mesenchymal stem cells in health and disease

  2008cited by this paper
• Mesenchymal cells recruit and regulate T regulatory cells.

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008influential reference
• Acute GvHD: pathogenesis and classification

  2008influential reference
• Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.

  2007cited by this paper
• How I treat refractory acute GVHD.

  2007influential reference
• An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• Hematopoietic stem-cell transplantation.

  2006cited by this paper
• Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

  2006cited by this paper
• Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

  2005cited by this paper
• Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

  2005cited by this paper
• Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

  2005cited by this paper
• Pentostatin in steroid-refractory acute graft-versus-host disease.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

  2004cited by this paper
• Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

  2004cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004cited by this paper
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cited by this paper
• Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

  2003cited by this paper
• Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

  2002cited by this paper
• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

  2002cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment.

  2002cited by this paper
• Acute graft-vs-host disease: pathobiology and management.

  2001influential reference
• Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.

  2000cited by this paper
• Marrow stromal stem cells.

  2000cited by this paper
• Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations.

  2000cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.

  1998cited by this paper
• Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

  1997cited by this paper
• Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemaia on Patients' outcome

  1994cited by this paper
• Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome.

  1994cited by this paper
• Marrow stromal stem cells

  1988cited by this paper
• Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.

  1985influential reference
• Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience

  1985cited by this paper
• Clarification of nomenclature.

  1977cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method.

  1974cited by this paper
• Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method.

  1974cited by this paper

• Artificial intelligence and systems biology analysis in stem cell research and therapeutics development

  2025cites this paper
• Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions.

  2025cites this paper
• The Effect of Storage Conditions on Mesenchymal Stem Cells in Breast Milk: A Randomized Study

  2025cites this paper
• A phase 1b study on the safety of Wharton's jelly mesenchymal stromal cells in the treatment of acute graft-versus-host disease.

  2025cites this paper
• Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta

  2025cites this paper
• Mesenchymal stromal cells for steroid-refractory biopsy-proven grade III-IV acute Graft-versus-Host Disease with predominant gastrointestinal involvement

  2025cites this paper
• Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience

  2024cites this paper
• Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?

  2024cites this paper
• Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up

  2024cites this paper
• Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study

  2024cites this paper
• The Treatment of Steroid-Refractory Severe Gastrointestinal Acute Graft-Versus-Host Disease in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Centre Experience

  2024cites this paper
• Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease

  2024cites this paper
• Mesenchymal Stem Cell Applications in Graft Versus Host Disease

  2024cites this paper
• Extracellular vesicles derived from bovine adipose-derived mesenchymal stromal cells enhance in vitro embryo production from lesioned ovaries.

  2024cites this paper
• Are mesenchymal stem cells still effective in acute GvHD management?

  2024cites this paper
• New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature

  2024cites this paper
• Understanding and treatment of cutaneous graft-versus-host-disease

  2023cites this paper
• Allogeneic Mesenchymal Stromal Cells as a Global Pediatric Prospective Approach in the Treatment of Respiratory Failure Associated with Surfactant Protein C Dysfunction

  2023cites this paper
• TITLE: New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs.

  2023cites this paper
• Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.

  2023cites this paper
• A review of the application of mesenchymal stem cells in the field of hematopoietic stem cell transplantation

  2023cites this paper
• Potential optimized route for mesenchymal stem cell transplantation in a rat model of cerebral palsy.

  2023cites this paper
• International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

  2023cites this paper
• Current perspectives on mesenchymal stromal cell therapy for graft versus host disease

  2023cites this paper
• Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases

  2023cites this paper
• Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications

  2023cites this paper
• Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency

  2023cites this paper
• Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

  2023cites this paper
• Treatment of steroid-refractory graft versus host disease in children

  2023cites this paper
• Efficacy of off-the-shelf bone marrow mesenchymal stem cells for pediatric steroid-refractory acute graft-versus-host disease

  2023cites this paper
• Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis

  2022cites this paper
• A Comparative Study of the Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells (MSCs) Efficiency on Generating MSC-Educated Macrophages (MEMs)

  2022cites this paper
• Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

  2022cites this paper
• Mesenchymal stroma/stem cells: Haematologists’ friend or foe?

  2022influential citation
• Mesenchymal stem cells to treat female infertility; future perspective and challenges: A review

  2022cites this paper
• A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies.

  2022cites this paper
• Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization

  2022cites this paper
• CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties

  2022influential citation
• New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury

  2022cites this paper
• Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

  2022cites this paper
• Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review

  2022influential citation
• Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials

  2022cites this paper
• A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease

  2022cites this paper
• Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

  2022cites this paper
• Successful treatment of steroid-dependent gastrointestinal acute graft-versus-host disease with mesenchymal stromal cells administered more than 100 days after allo-HCT

  2022cites this paper
• Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence

  2021cites this paper
• Challenges, highlights, and opportunities in cellular transplantation: A white paper of the current landscape

  2021cites this paper
• Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases

  2021cites this paper
• Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice by co-transplantation of syngeneic human umbilical cord-derived mesenchymal stromal cells (UC-MSCs).

  2021cites this paper
• Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment.

  2021cites this paper
• A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance

  2021cites this paper
• Erectile Dysfunction Treatment Using Stem Cells: A Review

  2021cites this paper
• Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantation

  2021cites this paper
• Efficacy and Safety of Mesenchymal Stromal cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis.

  2021cites this paper
• Mesenchymal–Hematopoietic Stem Cell Axis: Applications for Induction of Hematopoietic Chimerism and Therapies for Malignancies

  2021cites this paper
• Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells.

  2021cites this paper
• Characterization of Bone Marrow Progenitor Cell Uterine Engraftment and Transdifferentiation

  2021cites this paper
• Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products

  2021cites this paper
• Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy.

  2021cites this paper
• Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease

  2021cites this paper
• Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.

  2020cites this paper
• Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application

  2020cites this paper
• Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA‐associated respiratory failure in the pediatric setting

  2020cites this paper
• Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

  2020cites this paper
• New Insights on the Role of the Mesenchymal–Hematopoietic Stem Cell Axis in Autologous and Allogeneic Hematopoiesis

  2020cites this paper
• Molecular Crosstalk Between Macrophages and Mesenchymal Stromal Cells

  2020cites this paper
• Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial

  2020cites this paper
• A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease

  2020cites this paper
• Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease

  2020cites this paper
• Можливість використання стовбурових клітин при трансплантації нирки: експериментальні дослідження (огляд літератури)

  2020cites this paper
• Mesenchymal stromal cells for osteonecrosis

  2020cites this paper
• Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

  2020cites this paper
• Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application

  2020cites this paper
• GVHD-derived plasma as a priming strategy of mesenchymal stem cells

  2020cites this paper
• Intraovarian injection of mesenchymal stem cells improves oocyte yield and in vitro embryo production in a bovine model of fertility loss

  2020cites this paper
• Allogeneic Bone Marrow Mesenchymal Stromal Cell Therapy in Patients with Steroid-Refractory Graft Versus Host Disease—a Pilot Study from Pakistan

  2020cites this paper
• [Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment].

  2020cites this paper
• Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

  2020influential citation
• Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee.

  2020cites this paper
• Infusion of Mesenchymal Stem Cells to Treat Graft Versus Host Disease: the Role of HLA-G and the Impact of its Polymorphisms

  2020cites this paper
• Extended Treatment With Mesenchymal Stromal Cells-Frankfurt am Main (MSC-FFM, Obnitix) in a Pediatric Patient With Steroid-refractory Acute Gastrointestinal Graft-Versus-Host Disease (GVHD): Case Report and Review of the Literature.

  2020cites this paper
• Effects of microcarriers addition and mixing on WJ-MSC culture in bioreactors

  2020cites this paper
• Developing cell therapies as drug products

  2020cites this paper
• Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers

  2020cites this paper
• Применение мультипотентных мезенхимальных стромальных клеток костного мозга при трансплантации почки

  2019cites this paper
• Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels

  2019cites this paper
• Inpatient Management of Mucocutaneous GVHD

  2019cites this paper
• Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency

  2019cites this paper
• Use of Mesenchymal Stem/Stromal Cells for Pediatric Orthopedic Applications

  2019cites this paper
• In Vitro Mesenchymal Progenitor Cell Expansion is a Predictor of Transplant-related Mortality and acute GvHD III-IV After Bone Marrow Transplantation in Univariate Analysis: A Large Single-Center Experience

  2019cites this paper
• Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling

  2019cites this paper
• Pediatric Pulmonology

  2019cites this paper
• Inhibitory effect of TGF-β gene modified human amniotic mesenchymal stem cells on rejection after xenotransplantation of peripheral nerves.

  2019cites this paper
• Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead.

  2019cites this paper
• Mesenchymal Stem (Stromal) Cell Communications in Their Niche and Beyond: The Role of Extra Cellular Vesicles and Organelle Transfer in Lung Regeneration

  2019cites this paper
• Mesenchymal Stem Cell Therapy Overcomes Steroid Resistance in Severe Gastrointestinal Acute Graft-Versus-Host Disease

  2019cites this paper
• Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.

  2019cites this paper
• Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival

  2019cites this paper
• Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease

  2019cites this paper
• Current understanding of the immunosuppressive properties of mesenchymal stromal cells

  2019cites this paper